tranexamic acid Ampoules, injection 50 mg/ml - 5 ml
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
Ukraine
Manufacturer #16213
The company's history stretches back to the 1990s when it began producing infusion solutions. By accumulating influence and experience in the sector, a newly founded company began its activities in the Eastern European pharmaceutical market with minimal production capacity. The company's strategy was shaped by the economic situation in the pharmaceutical market at the time, expanding corporate competition, and the need for future development.
Manufacturer usually replies in 3 days
Tranexamic acid is a coagulation modifier class medication that is used to prevent blood loss after major trauma, factor IX deficiency, hemophilia type A, melasma, nosebleeds, menorrhagia, and menstrual disorders. Manufacturing companies produce it as both standalone medication and in combination drug formulations, along with ingredients such as etamsylate and mefenamic acid.
Suppliers market it in the forms of 100mg/ml solution for intravenous injection and 500mg tablets.
In use for over 50 years, tranexamic acid is an inexpensive and widely used treatment. The World Health Organisation has included it in its list of Essential Medicines that contains the safest and most effective drugs recommended for a health system. Major pharmaceutical manufacturers and supplies of tranexamic acid include Pfizer and Sanofi-Aventis.
Tranexamic acid is available in both trade name and generic formulations. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.